Compile Data Set for Download or QSAR
Report error Found 40 Enz. Inhib. hit(s) with all data for entry = 12817
TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730413(US20250122166, Compound 3)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730445(US20250122166, Compound 40)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730443(US20250122166, Compound 38)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730444(US20250122166, Compound 39)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730441(US20250122166, Compound 36)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730440(US20250122166, Compound 35)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730420(US20250122166, Compound 15)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730449(US20250122166, Compound 44)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730427(US20250122166, Compound 22)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730426(US20250122166, Compound 21)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730423(US20250122166, Compound 18)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730438(US20250122166, Compound 33)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730435(US20250122166, Compound 30)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730433(US20250122166, Compound 28)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730431(US20250122166, Compound 26)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730432(US20250122166, Compound 27)
Affinity DataIC50: 1.00E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730414(US20250122166, Compound 4)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730446(US20250122166, Compound 41)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730301(US20250122166, Compound 1)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730442(US20250122166, Compound 37)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730439(US20250122166, Compound 34)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730421(US20250122166, Compound 16)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730422(US20250122166, Compound 17)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730419(US20250122166, Compound 13)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730451(US20250122166, Compound 46)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730417(US20250122166, Compound 9)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730418(US20250122166, Compound 12)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730450(US20250122166, Compound 45)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730415(US20250122166, Compound 5)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730447(US20250122166, Compound 42)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730416(US20250122166, Compound 7)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730448(US20250122166, Compound 43)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730429(US20250122166, Compound 24)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730428(US20250122166, Compound 23)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730425(US20250122166, Compound 20)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730424(US20250122166, Compound 19)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730437(US20250122166, Compound 32)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730436(US20250122166, Compound 31)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730434(US20250122166, Compound 29)
Affinity DataIC50: 5.50E+3nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL, INC.

US Patent
LigandPNGBDBM730430(US20250122166, Compound 25)
Affinity DataIC50: 1.00E+4nMAssay Description:In this competitive fluorescent polarization assay Cy5 conjugated lenalidomide analog (Cy5—O-Len)1 was used as a fluorescent probe. 6XHis-CRBN-DDB1 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent